iPhone | iPad
Android
HuaweiLead in ginkgo pills. Arsenic in herbals. Bugs in a baby’s colic and teething syrup. Toxic metals and parasites are part of nature, and all of these have been found in 'natural' products and dietary supplements in recent years.
KT APPDOWNLOAD
MORE FROM Health
WASHINGTON - Obesity among adolescents could be linked to reduced sleep, according to the latest research. A reduction in sleep could be associated with more hours of technology use, a higher caffeine intake as well as increased symptoms of sleep disorders, such as snoring.
Pregnant women who consume extra calories and gain too much weight may face complications at birth such as pre-eclampsia (hypertension), or may require a C-section. Moreover, both mother and child face a higher risk of being obese later in life.
CHICAGO - Middle-aged adults who get too little sleep are more likely to develop high blood pressure, U.S. researchers said on Monday.
NEW DELHI - Smoking is injurious to health - and more so for women. According to doctors, smoking can lead to multiple complications in women and the very first heart attack could lead to sudden death.
CHICAGO - Diabetics with stable heart disease do just as well taking drugs alone as getting quick angioplasty or bypass surgery to open blocked heart arteries, U.S. researchers said on Sunday.
BALTIMORE – At one of the nation’s top trauma hospitals, a nurse circles a patient’s bed, humming and waving her arms as if shooing evil spirits. Another woman rubs a quartz bowl with a wand, making tunes that mix with the beeping monitors and hissing respirator keeping the man alive.
WASHINGTON - Our hunger pangs are activated not by an empty stomach but by fats from the foods we eat to optimise nutrient metabolism and promote the storage of body fat, according to latest research.
LONDON - Middle-aged women are more stressed today but have lower blood pressure levels, a long-term study carried out in Sweden has revealed.
WASHINGTON - Three antipsychotic drugs appear to work in children and teens but their risks must be weighed as the makers seek to promote them for younger patients, the head of the U.S. Food and Drug Administration’s psychiatric division said in a memo released on Friday.
